Europe Cancer Immunotherapy Market Report 2017

February 2017 | 125 pages | ID: ED0D1FC6742EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Cancer Immunotherapy

Revenue, means the sales value of Cancer Immunotherapy

This report studies sales (consumption) of Cancer Immunotherapy in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Amgen
• AstraZeneca
• F. Hoffman La-Roche
• Bayer AG
• Bristol-Myers Squibb
• Eli Lilly and Company
• Janssen Global Services
• Merck
• Novartis
• Pfizer
• Seattle Genetics
• Peregrine Pharmaceuticals
• Viralytics Ltd
• Immunomedics

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Cancer Immunotherapy in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Melanoma
• Colorectal cancer
• Prostate cancer
• Head and neck cancer
• Breast cancer
• Lung cancer
• Other

Split by application, this report focuses on sales, market share and growth rate of Cancer Immunotherapy in each application, can be divided into

• Hospitals
• Clinics
• Others

Contents

Europe Cancer Immunotherapy Market Report 2017

1 CANCER IMMUNOTHERAPY OVERVIEW

1.1 Product Overview and Scope of Cancer Immunotherapy
1.2 Classification of Cancer Immunotherapy
  1.2.1 Melanoma
  1.2.2 Colorectal cancer
  1.2.3 Prostate cancer
  1.2.4 Head and neck cancer
  1.2.5 Breast cancer
  1.2.6 Lung cancer
  1.2.7 Other
1.3 Application of Cancer Immunotherapy
  1.3.1 Hospitals
  1.3.2 Clinics
  1.3.3 Others
1.4 Cancer Immunotherapy Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Cancer Immunotherapy (2011-2021)
  1.5.1 Europe Cancer Immunotherapy Sales and Growth Rate (2011-2021)
  1.5.2 Europe Cancer Immunotherapy Revenue and Growth Rate (2011-2021)

2 EUROPE CANCER IMMUNOTHERAPY BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Cancer Immunotherapy Market Competition by Manufacturers
  2.1.1 Europe Cancer Immunotherapy Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Cancer Immunotherapy Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Cancer Immunotherapy (Volume and Value) by Type
  2.2.1 Europe Cancer Immunotherapy Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Cancer Immunotherapy Revenue and Market Share by Type (2011-2016)
2.3 Europe Cancer Immunotherapy (Volume and Value) by Countries
  2.3.1 Europe Cancer Immunotherapy Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Cancer Immunotherapy Revenue and Market Share by Countries (2011-2016)
2.4 Europe Cancer Immunotherapy (Volume) by Application

3 GERMANY CANCER IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Cancer Immunotherapy Sales and Value (2011-2016)
  3.1.1 Germany Cancer Immunotherapy Sales and Growth Rate (2011-2016)
  3.1.2 Germany Cancer Immunotherapy Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Cancer Immunotherapy Sales Price Trend (2011-2016)
3.2 Germany Cancer Immunotherapy Sales and Market Share by Manufacturers
3.3 Germany Cancer Immunotherapy Sales and Market Share by Type
3.4 Germany Cancer Immunotherapy Sales and Market Share by Application

4 FRANCE CANCER IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

4.1 France Cancer Immunotherapy Sales and Value (2011-2016)
  4.1.1 France Cancer Immunotherapy Sales and Growth Rate (2011-2016)
  4.1.2 France Cancer Immunotherapy Revenue and Growth Rate (2011-2016)
  4.1.4 France Cancer Immunotherapy Sales Price Trend (2011-2016)
4.2 France Cancer Immunotherapy Sales and Market Share by Manufacturers
4.3 France Cancer Immunotherapy Sales and Market Share by Type
4.4 France Cancer Immunotherapy Sales and Market Share by Application

5 UK CANCER IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

5.1 UK Cancer Immunotherapy Sales and Value (2011-2016)
  5.1.1 UK Cancer Immunotherapy Sales and Growth Rate (2011-2016)
  5.1.2 UK Cancer Immunotherapy Revenue and Growth Rate (2011-2016)
  5.1.5 UK Cancer Immunotherapy Sales Price Trend (2011-2016)
5.2 UK Cancer Immunotherapy Sales and Market Share by Manufacturers
5.3 UK Cancer Immunotherapy Sales and Market Share by Type
5.4 UK Cancer Immunotherapy Sales and Market Share by Application

6 RUSSIA CANCER IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Cancer Immunotherapy Sales and Value (2011-2016)
  6.1.1 Russia Cancer Immunotherapy Sales and Growth Rate (2011-2016)
  6.1.2 Russia Cancer Immunotherapy Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Cancer Immunotherapy Sales Price Trend (2011-2016)
6.2 Russia Cancer Immunotherapy Sales and Market Share by Manufacturers
6.3 Russia Cancer Immunotherapy Sales and Market Share by Type
6.4 Russia Cancer Immunotherapy Sales and Market Share by Application

7 ITALY CANCER IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Cancer Immunotherapy Sales and Value (2011-2016)
  7.1.1 Italy Cancer Immunotherapy Sales and Growth Rate (2011-2016)
  7.1.2 Italy Cancer Immunotherapy Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Cancer Immunotherapy Sales Price Trend (2011-2016)
7.2 Italy Cancer Immunotherapy Sales and Market Share by Manufacturers
7.3 Italy Cancer Immunotherapy Sales and Market Share by Type
7.4 Italy Cancer Immunotherapy Sales and Market Share by Application

8 SPAIN CANCER IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Cancer Immunotherapy Sales and Value (2011-2016)
  8.1.1 Spain Cancer Immunotherapy Sales and Growth Rate (2011-2016)
  8.1.2 Spain Cancer Immunotherapy Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Cancer Immunotherapy Sales Price Trend (2011-2016)
8.2 Spain Cancer Immunotherapy Sales and Market Share by Manufacturers
8.3 Spain Cancer Immunotherapy Sales and Market Share by Type
8.4 Spain Cancer Immunotherapy Sales and Market Share by Application

9 BENELUX CANCER IMMUNOTHERAPY (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Cancer Immunotherapy Sales and Value (2011-2016)
  9.1.1 Benelux Cancer Immunotherapy Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Cancer Immunotherapy Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Cancer Immunotherapy Sales Price Trend (2011-2016)
9.2 Benelux Cancer Immunotherapy Sales and Market Share by Manufacturers
9.3 Benelux Cancer Immunotherapy Sales and Market Share by Type
9.4 Benelux Cancer Immunotherapy Sales and Market Share by Application

10 EUROPE CANCER IMMUNOTHERAPY MANUFACTURERS ANALYSIS

10.1 Amgen
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Cancer Immunotherapy Product Type, Application and Specification
    10.1.2.1 Melanoma
    10.1.2.2 Colorectal cancer
  10.1.3 Amgen Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 AstraZeneca
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Cancer Immunotherapy Product Type, Application and Specification
    10.2.2.1 Melanoma
    10.2.2.2 Colorectal cancer
  10.2.3 AstraZeneca Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 F. Hoffman La-Roche
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Cancer Immunotherapy Product Type, Application and Specification
    10.3.2.1 Melanoma
    10.3.2.2 Colorectal cancer
  10.3.3 F. Hoffman La-Roche Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Bayer AG
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Cancer Immunotherapy Product Type, Application and Specification
    10.4.2.1 Melanoma
    10.4.2.2 Colorectal cancer
  10.4.3 Bayer AG Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Bristol-Myers Squibb
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Cancer Immunotherapy Product Type, Application and Specification
    10.5.2.1 Melanoma
    10.5.2.2 Colorectal cancer
  10.5.3 Bristol-Myers Squibb Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Eli Lilly and Company
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Cancer Immunotherapy Product Type, Application and Specification
    10.6.2.1 Melanoma
    10.6.2.2 Colorectal cancer
  10.6.3 Eli Lilly and Company Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 Janssen Global Services
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Cancer Immunotherapy Product Type, Application and Specification
    10.7.2.1 Melanoma
    10.7.2.2 Colorectal cancer
  10.7.3 Janssen Global Services Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Merck
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Cancer Immunotherapy Product Type, Application and Specification
    10.8.2.1 Melanoma
    10.8.2.2 Colorectal cancer
  10.8.3 Merck Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Novartis
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Cancer Immunotherapy Product Type, Application and Specification
    10.9.2.1 Melanoma
    10.9.2.2 Colorectal cancer
  10.9.3 Novartis Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 Pfizer
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Cancer Immunotherapy Product Type, Application and Specification
    10.10.2.1 Melanoma
    10.10.2.2 Colorectal cancer
  10.10.3 Pfizer Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview
10.11 Seattle Genetics
10.12 Peregrine Pharmaceuticals
10.13 Viralytics Ltd
10.14 Immunomedics

11 CANCER IMMUNOTHERAPY MANUFACTURING COST ANALYSIS

11.1 Cancer Immunotherapy Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Cancer Immunotherapy

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Cancer Immunotherapy Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Cancer Immunotherapy Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE CANCER IMMUNOTHERAPY MARKET FORECAST (2016-2021)

14.1 Germany Cancer Immunotherapy Sales Forecast (2016-2021)
14.2 France Cancer Immunotherapy Sales Forecast (2016-2021)
14.3 UK Cancer Immunotherapy Sales Forecast (2016-2021)
14.4 Russia Cancer Immunotherapy Sales Forecast (2016-2021)
14.5 Italy Cancer Immunotherapy Sales Forecast (2016-2021)
14.6 Spain Cancer Immunotherapy Sales Forecast (2016-2021)
14.7 Benelux Cancer Immunotherapy Sales Forecast (2016-2021)
14.8 Europe Cancer Immunotherapy Sales Forecast by Type (2016-2021)
14.9 Europe Cancer Immunotherapy Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Cancer Immunotherapy
Table Classification of Cancer Immunotherapy
Figure Europe Sales Market Share of Cancer Immunotherapy by Type in 2015
Figure Melanoma Picture
Figure Colorectal cancer Picture
Figure Prostate cancer Picture
Figure Head and neck cancer Picture
Figure Breast cancer Picture
Figure Lung cancer Picture
Figure Other Picture
Table Application of Cancer Immunotherapy
Figure Europe Sales Market Share of Cancer Immunotherapy by Application in 2015
Figure Hospitals Examples
Figure Clinics Examples
Figure Others Examples
Figure Germany Cancer Immunotherapy Revenue and Growth Rate (2011-2021)
Figure France Cancer Immunotherapy Revenue and Growth Rate (2011-2021)
Figure UK Cancer Immunotherapy Revenue and Growth Rate (2011-2021)
Figure Russia Cancer Immunotherapy Revenue and Growth Rate (2011-2021)
Figure Italy Cancer Immunotherapy Revenue and Growth Rate (2011-2021)
Figure Spain Cancer Immunotherapy Revenue and Growth Rate (2011-2021)
Figure Benelux Cancer Immunotherapy Revenue and Growth Rate (2011-2021)
Figure Europe Cancer Immunotherapy Sales and Growth Rate (2011-2021)
Figure Europe Cancer Immunotherapy Revenue and Growth Rate (2011-2021)
Table Europe Cancer Immunotherapy Sales of Key Manufacturers (2015 and 2016)
Table Europe Cancer Immunotherapy Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Immunotherapy Sales Share by Manufacturers
Figure 2016 Cancer Immunotherapy Sales Share by Manufacturers
Table Europe Cancer Immunotherapy Revenue by Manufacturers (2015 and 2016)
Table Europe Cancer Immunotherapy Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Cancer Immunotherapy Revenue Share by Manufacturers
Table 2016 Europe Cancer Immunotherapy Revenue Share by Manufacturers
Table Europe Cancer Immunotherapy Sales and Market Share by Type (2011-2016)
Table Europe Cancer Immunotherapy Sales Share by Type (2011-2016)
Figure Sales Market Share of Cancer Immunotherapy by Type (2011-2016)
Figure Europe Cancer Immunotherapy Sales Growth Rate by Type (2011-2016)
Table Europe Cancer Immunotherapy Revenue and Market Share by Type (2011-2016)
Table Europe Cancer Immunotherapy Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Cancer Immunotherapy by Type (2011-2016)
Figure Europe Cancer Immunotherapy Revenue Growth Rate by Type (2011-2016)
Table Europe Cancer Immunotherapy Sales and Market Share by Countries (2011-2016)
Table Europe Cancer Immunotherapy Sales Share by Countries (2011-2016)
Figure Sales Market Share of Cancer Immunotherapy by Countries (2011-2016)
Table Europe Cancer Immunotherapy Revenue and Market Share by Countries (2011-2016)
Table Europe Cancer Immunotherapy Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Cancer Immunotherapy by Countries (2011-2016)
Table Europe Cancer Immunotherapy Sales and Market Share by Application (2011-2016)
Table Europe Cancer Immunotherapy Sales Share by Application (2011-2016)
Figure Sales Market Share of Cancer Immunotherapy by Application (2011-2016)
Figure Germany Cancer Immunotherapy Sales and Growth Rate (2011-2016)
Figure Germany Cancer Immunotherapy Revenue and Growth Rate (2011-2016)
Figure Germany Cancer Immunotherapy Sales Price Trend (2011-2016)
Table Germany Cancer Immunotherapy Sales by Manufacturers (2015 and 2016)
Table Germany Cancer Immunotherapy Market Share by Manufacturers (2015 and 2016)
Table Germany Cancer Immunotherapy Sales by Type (2015 and 2016)
Table Germany Cancer Immunotherapy Market Share by Type (2015 and 2016)
Table Germany Cancer Immunotherapy Sales by Application (2015 and 2016)
Table Germany Cancer Immunotherapy Market Share by Application (2015 and 2016)
Figure France Cancer Immunotherapy Sales and Growth Rate (2011-2016)
Figure France Cancer Immunotherapy Revenue and Growth Rate (2011-2016)
Figure France Cancer Immunotherapy Sales Price Trend (2011-2016)
Table France Cancer Immunotherapy Sales by Manufacturers (2015 and 2016)
Table France Cancer Immunotherapy Market Share by Manufacturers (2015 and 2016)
Table France Cancer Immunotherapy Sales by Type (2015 and 2016)
Table France Cancer Immunotherapy Market Share by Type (2015 and 2016)
Table France Cancer Immunotherapy Sales by Application (2015 and 2016)
Table France Cancer Immunotherapy Market Share by Application (2015 and 2016)
Figure UK Cancer Immunotherapy Sales and Growth Rate (2011-2016)
Figure UK Cancer Immunotherapy Revenue and Growth Rate (2011-2016)
Figure UK Cancer Immunotherapy Sales Price Trend (2011-2016)
Table UK Cancer Immunotherapy Sales by Manufacturers (2015 and 2016)
Table UK Cancer Immunotherapy Market Share by Manufacturers (2015 and 2016)
Table UK Cancer Immunotherapy Sales by Type (2015 and 2016)
Table UK Cancer Immunotherapy Market Share by Type (2015 and 2016)
Table UK Cancer Immunotherapy Sales by Application (2015 and 2016)
Table UK Cancer Immunotherapy Market Share by Application (2015 and 2016)
Figure Russia Cancer Immunotherapy Sales and Growth Rate (2011-2016)
Figure Russia Cancer Immunotherapy Revenue and Growth Rate (2011-2016)
Figure Russia Cancer Immunotherapy Sales Price Trend (2011-2016)
Table Russia Cancer Immunotherapy Sales by Manufacturers (2015 and 2016)
Table Russia Cancer Immunotherapy Market Share by Manufacturers (2015 and 2016)
Table Russia Cancer Immunotherapy Sales by Type (2015 and 2016)
Table Russia Cancer Immunotherapy Market Share by Type (2015 and 2016)
Table Russia Cancer Immunotherapy Sales by Application (2015 and 2016)
Table Russia Cancer Immunotherapy Market Share by Application (2015 and 2016)
Figure Italy Cancer Immunotherapy Sales and Growth Rate (2011-2016)
Figure Italy Cancer Immunotherapy Revenue and Growth Rate (2011-2016)
Figure Italy Cancer Immunotherapy Sales Price Trend (2011-2016)
Table Italy Cancer Immunotherapy Sales by Manufacturers (2015 and 2016)
Table Italy Cancer Immunotherapy Market Share by Manufacturers (2015 and 2016)
Table Italy Cancer Immunotherapy Sales by Type (2015 and 2016)
Table Italy Cancer Immunotherapy Market Share by Type (2015 and 2016)
Table Italy Cancer Immunotherapy Sales by Application (2015 and 2016)
Table Italy Cancer Immunotherapy Market Share by Application (2015 and 2016)
Figure Spain Cancer Immunotherapy Sales and Growth Rate (2011-2016)
Figure Spain Cancer Immunotherapy Revenue and Growth Rate (2011-2016)
Figure Spain Cancer Immunotherapy Sales Price Trend (2011-2016)
Table Spain Cancer Immunotherapy Sales by Manufacturers (2015 and 2016)
Table Spain Cancer Immunotherapy Market Share by Manufacturers (2015 and 2016)
Table Spain Cancer Immunotherapy Sales by Type (2015 and 2016)
Table Spain Cancer Immunotherapy Market Share by Type (2015 and 2016)
Table Spain Cancer Immunotherapy Sales by Application (2015 and 2016)
Table Spain Cancer Immunotherapy Market Share by Application (2015 and 2016)
Figure Benelux Cancer Immunotherapy Sales and Growth Rate (2011-2016)
Figure Benelux Cancer Immunotherapy Revenue and Growth Rate (2011-2016)
Figure Benelux Cancer Immunotherapy Sales Price Trend (2011-2016)
Table Benelux Cancer Immunotherapy Sales by Manufacturers (2015 and 2016)
Table Benelux Cancer Immunotherapy Market Share by Manufacturers (2015 and 2016)
Table Benelux Cancer Immunotherapy Sales by Type (2015 and 2016)
Table Benelux Cancer Immunotherapy Market Share by Type (2015 and 2016)
Table Benelux Cancer Immunotherapy Sales by Application (2015 and 2016)
Table Benelux Cancer Immunotherapy Market Share by Application (2015 and 2016)
Table Cancer Immunotherapy Basic Information List
Table Amgen Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Cancer Immunotherapy Sales Market Share (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Cancer Immunotherapy Sales Market Share (2011-2016)
Table F. Hoffman La-Roche Basic Information List
Table F. Hoffman La-Roche Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table F. Hoffman La-Roche Cancer Immunotherapy Sales Market Share (2011-2016)
Table Bayer AG Basic Information List
Table Bayer AG Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer AG Cancer Immunotherapy Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Cancer Immunotherapy Sales Market Share (2011-2016)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company Cancer Immunotherapy Sales Market Share (2011-2016)
Table Janssen Global Services Basic Information List
Table Janssen Global Services Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Janssen Global Services Cancer Immunotherapy Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Cancer Immunotherapy Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Cancer Immunotherapy Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Cancer Immunotherapy Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Cancer Immunotherapy Sales Market Share (2011-2016)
Table Seattle Genetics Basic Information List
Table Peregrine Pharmaceuticals Basic Information List
Table Viralytics Ltd Basic Information List
Table Immunomedics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Immunotherapy
Figure Manufacturing Process Analysis of Cancer Immunotherapy
Figure Cancer Immunotherapy Industrial Chain Analysis
Table Raw Materials Sources of Cancer Immunotherapy Major Manufacturers in 2015
Table Major Buyers of Cancer Immunotherapy
Table Distributors/Traders List
Figure Germany Cancer Immunotherapy Sales and Growth Rate Forecast (2016-2021)
Figure Germany Cancer Immunotherapy Revenue and Growth Rate Forecast (2016-2021)
Figure France Cancer Immunotherapy Sales and Growth Rate Forecast (2016-2021)
Figure France Cancer Immunotherapy Revenue and Growth Rate Forecast (2016-2021)
Figure UK Cancer Immunotherapy Sales and Growth Rate Forecast (2016-2021)
Figure UK Cancer Immunotherapy Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Cancer Immunotherapy Sales and Growth Rate Forecast (2016-2021)
Figure Russia Cancer Immunotherapy Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Cancer Immunotherapy Sales and Growth Rate Forecast (2016-2021)
Figure Italy Cancer Immunotherapy Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Cancer Immunotherapy Sales and Growth Rate Forecast (2016-2021)
Figure Spain Cancer Immunotherapy Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Cancer Immunotherapy Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Cancer Immunotherapy Revenue and Growth Rate Forecast (2016-2021)
Table Europe Cancer Immunotherapy Sales Forecast by Type (2016-2021)
Table Europe Cancer Immunotherapy Sales Forecast by Application (2016-2021)